Nanodynamic therapies that generate free radicals/reactive oxygen species (ROS) in situ
have the possibility to treat deep-seated tumors and have gradually become attractive …

Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …

Nano‐immunotherapy has been recognized as a highly promising strategy for cancer
treatment in recent decades, which combines nanotechnology and immunotherapy to …

Immunogenic cell death (ICD) is a unique mode of cell death, which can release
immunogenic damage‐associated molecular patterns (DAMPs) and tumor‐associated …

Cancer immunotherapy has achieved tremendous successful clinical results and obtained
historic victories in tumor treatments. However, great limitations associated with feeble …

Radiotherapy-resistant glioblastoma (rrGBM) remains a significant clinical challenge
because of high infiltrative growth characterized by activation of antiapoptotic signal …

Effective tumor treatment depends on optimizing drug penetration and accumulation in
tumor tissue while minimizing systemic toxicity. Nanomedicine has emerged as a key …

The global menace of cancer has led to an increased death toll in recent years. The constant
evolution of cancer therapeutics with novel delivery systems has paved the way for …

Chemo‐photodynamic therapy nanodelivery systems provide a potential strategy to
enhance anticancer effect. However, the treatment efficiency of stimuli‐responsive …

Bacterial infection and delayed osseointegration are two major challenges for titanium-
based orthopedic implants. In the present study, we developed a functionalized titanium …